Table 1.
ORF | Deleted or repressed gene |
Promotera | TM | Location | Role | |||
---|---|---|---|---|---|---|---|---|
L2b | A11c | A6d | A17e | |||||
A3 | U | U | U | Intermed | − | Core | MV formation | |
A4 | N | N | N | Early | − | Core | MV formation | |
A6 | D | Intermed | − | Cytoplasm | IV formation | |||
A10 | Nf | U | Late | − | MV core | MV formation | ||
A11 | D | Ng | N | Late | + | Cytoplasm | IV formation | |
A13 | N | Nh | Late | + | MV membrane | MV formation | ||
A14 | D, Gi | D, Gi | Gi | Late | + | IV, MV | IV formation | |
A16 | D | Intermed | + | MV membrane | EFC | |||
A17 | U | U | Late | + | IV, MV membrane | IV formation | ||
A21 | D | D | D | Late | + | MV membrane | EFC | |
A26 | D | D | D | Late | − | MV membrane | Cell attachment | |
A27 | N | Intermed | − | MV membrane | Cell attachment | |||
A28 | D | D | D | Late | + | MV membrane | EFC | |
A30 | N | N | Intermed | − | MV core | MV formation | ||
D8 | Nh | N | Nh | N | Intermed | + | IV, MV membrane | Cell attachment |
D13 | N | N | N | Intermed | − | IV outer | IV scaffold | |
F9 | D | D | D | D | Late | + | MV membrane | EFC |
F10 | D | D | Late | − | MV core | Kinase, IV formation | ||
F13 | N | N | N | Intermed | + | EV membrane | Wrapping | |
G3 | D | Late | + | MV membrane | EFC | |||
G4 | N | Intermed | − | MV membrane | Redox | |||
G7 | N | Late | − | MV core | Core complex | |||
H2 | D | Late | + | MV membrane | EFC | |||
H3 | D | Nh | Intermed | + | MV membrane | Cell attachment | ||
H7 | N | Intermed | − | Cytoplasm | IV formation | |||
J1 | N | Intermed | − | MV core | Core complex | |||
L1 | D | D | D | D | Late | + | MV membrane | EFC |
L2 | N | N | Early | + | ER | IV formation | ||
L5 | D | Late | + | MV membrane | EFC |
Data from reference 56.
Data from present study and reference 37.
Data from reference 33.
Data from reference 37.
Precursor and processed forms not resolved.
Mislocalized to cytoplasm.
ER localization.
Glycosylation and ER localization.
Abbreviations: D, decreased; U, unprocessed; N, normal; Intermed, intermediate; TM, transmembrane domain. Shading highlights proteins that are decreased when L2 is repressed or deleted.